Ari Gnanasakthy

Summary

Affiliation: Novartis Institutes for BioMedical Research

Publications

  1. pmc Secukinumab treatment in rheumatoid arthritis is associated with incremental benefit in the clinical outcomes and HRQoL improvements that exceed minimally important thresholds
    Vibeke Strand
    QualityMetric Incorporated, 24 Albion Road, Lincoln, RI, USA
    Health Qual Life Outcomes 12:31. 2014
  2. pmc Potential of patient-reported outcomes as nonprimary endpoints in clinical trials
    Ari Gnanasakthy
    Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
    Health Qual Life Outcomes 11:83. 2013
  3. ncbi Integration of patient-reported outcomes in multiregional confirmatory clinical trials
    Ari Gnanasakthy
    Novartis Pharmaceuticals Corporation, 1 Health Plaza East, Hanover, NJ, USA
    Contemp Clin Trials 35:62-9. 2013
  4. ncbi A review of patient-reported outcome labels in the United States: 2006 to 2010
    Ari Gnanasakthy
    Novartis Pharmaceuticals Corporation, East Hannover, NJ 07936, USA
    Value Health 15:437-42. 2012
  5. pmc Patient reported outcomes: looking beyond the label claim
    Lynda C Doward
    Galen Research Ltd, Enterprise House, Manchester Science Park, Lloyd Street North, Manchester, M15 6SE, UK
    Health Qual Life Outcomes 8:89. 2010

Collaborators

  • Vibeke Strand
  • Lynda C Doward
  • Mark Kosinski
  • Shephard Mpofu
  • Usha Mallya
  • Mary G Baker

Detail Information

Publications5

  1. pmc Secukinumab treatment in rheumatoid arthritis is associated with incremental benefit in the clinical outcomes and HRQoL improvements that exceed minimally important thresholds
    Vibeke Strand
    QualityMetric Incorporated, 24 Albion Road, Lincoln, RI, USA
    Health Qual Life Outcomes 12:31. 2014
    ....
  2. pmc Potential of patient-reported outcomes as nonprimary endpoints in clinical trials
    Ari Gnanasakthy
    Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
    Health Qual Life Outcomes 11:83. 2013
    ....
  3. ncbi Integration of patient-reported outcomes in multiregional confirmatory clinical trials
    Ari Gnanasakthy
    Novartis Pharmaceuticals Corporation, 1 Health Plaza East, Hanover, NJ, USA
    Contemp Clin Trials 35:62-9. 2013
    ..This paper presents these challenges and potential solutions...
  4. ncbi A review of patient-reported outcome labels in the United States: 2006 to 2010
    Ari Gnanasakthy
    Novartis Pharmaceuticals Corporation, East Hannover, NJ 07936, USA
    Value Health 15:437-42. 2012
    ....
  5. pmc Patient reported outcomes: looking beyond the label claim
    Lynda C Doward
    Galen Research Ltd, Enterprise House, Manchester Science Park, Lloyd Street North, Manchester, M15 6SE, UK
    Health Qual Life Outcomes 8:89. 2010
    ..The purpose of the current paper is to highlight the potential added value of patient reported outcome data currently collected and held by the industry for these groups...